This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ZIKAVAC (Inactivated Virus)

Bharat Biotech

Drug Names(s): Zika Vaccine, ZIKAVAC

Description: Bharat Biotech is developing ZIKAVAC, a Zika vaccine, using inactivated virus.

ZIKAVAC (Inactivated Virus) News

Scrip Doubling Up On Vaccines: A Combined Zika And Dengue Vaccine May Be Possible

Scrip Tech Transfer Roundup: Mustang Licenses St. Jude’s Gene Therapy For Bubble Boy Disease

Scrip Interview: BioNTech And Pfizer Explore mRNA Flu Vaccines In $120m+ Deal

Scrip ViiV/Janssen's Long-Acting Anti-HIV Injections Impress

Additional information available to subscribers only:

Targets
Routes
Catalysts
Designations
Events

Request a Free Demo Subscriber Login Search for another drug